Gabelli & Co Investment Advisers’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-125,400	Closed	-$789K	–	147
2013 Q2	$789K	Buy	+125,400	New	+$751K	0.21%	66

Other funds holding PBTH

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Gabelli & Co Investment Advisers's PBTH Position: Q3 2013 in Review

Gabelli & Co Investment Advisers sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 125,400 shares — an estimated $789K sold.

Gabelli & Co Investment Advisers first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $789K in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

Gabelli & Co Investment Advisers reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 125,400 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $789K.
Gabelli & Co Investment Advisers first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
Gabelli & Co Investment Advisers's PROLOR Biotech, Inc. Common Stock position peaked at $789K in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2013, filed 7 Nov 2013.